JPH09110677A - Aerosol preparation - Google Patents

Aerosol preparation

Info

Publication number
JPH09110677A
JPH09110677A JP8206774A JP20677496A JPH09110677A JP H09110677 A JPH09110677 A JP H09110677A JP 8206774 A JP8206774 A JP 8206774A JP 20677496 A JP20677496 A JP 20677496A JP H09110677 A JPH09110677 A JP H09110677A
Authority
JP
Japan
Prior art keywords
propellant
aerosol
menthol
weight
pruritus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8206774A
Other languages
Japanese (ja)
Inventor
Fumio Urushizaki
文男 漆崎
Haruo Shimamura
治夫 島村
Takeshi Uchiyama
剛 内山
Noritoshi Kimura
文紀 木村
Keiko Kato
恵子 加藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Priority to JP8206774A priority Critical patent/JPH09110677A/en
Publication of JPH09110677A publication Critical patent/JPH09110677A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain an aerosol preparation having excellent antipruritic effect to immediate reaction of pruritus by getting stung by an insect and also having excellent antipruritic effect to delayed reaction of pruritus. SOLUTION: This aerosol preparation is composed of a raw solution and a propellant obtained by blending a mixed solvent of water and a lower alcohol with following components (A)-(C): (A) one kind or more than two kinds of surfactant selected from the group comprising of polyoxyethylene fatty sorbitates and fatty sorbitates; (B) 0.5-8wt.% menthol and (C) 1-0.5 pt.wt. of camphor based on 1 pt.wt. of menthol.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、虫刺されや水虫などに
よる痒みに対する鎮痒効果の優れたエアゾール剤に関す
る。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an aerosol agent having an excellent antipruritic effect against pruritus caused by insect bites and athlete's foot.

【0002】[0002]

【従来の技術】虫刺されによる皮膚反応として、痒みや
発赤があり、その反応は刺咬数分後〜1時間後の即時反
応と十数時間〜1日後の遅延反応がある。このうち、遅
延反応の痒みについては、局所麻酔剤や鎮痒剤を配合し
た一般的な軟膏などの薬剤の塗布により抑えることがで
きる。これに対して即時反応の痒みについては、上記薬
剤の塗布では勿論、エタノールなどの原液成分の蒸発に
よる冷却や、単なる噴射剤の噴霧による冷却でも充分に
抑えることができなかった。
2. Description of the Related Art Skin reactions caused by insect bites include itching and redness, and there are an immediate reaction several minutes to one hour after the bite and a delayed reaction after ten and several hours to one day. Among them, the itching of delayed reaction can be suppressed by applying a drug such as a general ointment containing a local anesthetic or an antipruritic. On the other hand, itching of the immediate reaction could not be sufficiently suppressed not only by applying the above-mentioned chemicals but also by cooling by evaporation of the stock solution components such as ethanol or simply by spraying a propellant.

【0003】[0003]

【発明が解決しようとする課題】本発明の目的は、虫刺
されによる即時反応の痒みや水虫の痒みに対する鎮痒効
果に優れた製剤を提供することにある。
SUMMARY OF THE INVENTION An object of the present invention is to provide a preparation having an excellent antipruritic effect against itching of immediate reaction caused by insect bites and pruritus of athlete's foot.

【0004】[0004]

【課題を解決するための手段】本発明者らは鋭意研究を
進めた結果、ある特定の界面活性剤にメントール及びカ
ンフルを一定の割合で配合したエアゾール剤が、前記課
題を解決することを見いだし、本発明を完成した。すな
わち本発明は、水と低級アルコールとの混合溶媒に、次
の(A)〜(C)の成分を配合した原液及び噴射剤から
なるエアゾール剤である。 (A)ポリオキシエチレンソルビタン脂肪酸エステル類
及びソルビタン脂肪酸エステル類からなる群より選ばれ
る界面活性剤1種または2種以上 (B)メントール0.5〜8重量% (C)メントール1重量部に対して1〜0.5重量部の
カンフル。
As a result of intensive studies, the inventors of the present invention found that an aerosol formulation containing menthol and camphor at a certain ratio in a specific surfactant can solve the above-mentioned problems. The present invention has been completed. That is, the present invention is an aerosol agent comprising a stock solution and a propellant in which the following components (A) to (C) are mixed in a mixed solvent of water and a lower alcohol. (A) one or more surfactants selected from the group consisting of polyoxyethylene sorbitan fatty acid esters and sorbitan fatty acid esters (B) menthol 0.5 to 8 wt% (C) to 1 part by weight of menthol 1 to 0.5 parts by weight camphor.

【0005】本発明において用いる、ポリオキシエチレ
ンソルビタン脂肪酸エステル類及びソルビタン脂肪酸エ
ステル類からなる群より選ばれる界面活性剤とは、原液
調製時に室温においてペースト状または半固形状となる
ものであり、ポリオキシエチレン(6)ソルビタンモノ
ステアレート単独あるいはポリオキシエチレン(20)
ソルビタンモノステアレート、ポリオキシエチレン(2
0)ソルビタントリステアレート及びソルビタンモノス
テアレートの混合物が好ましい。これらの配合量は0.
5〜8重量%好ましくは0.5〜4重量%である。
The surfactant used in the present invention, which is selected from the group consisting of polyoxyethylene sorbitan fatty acid esters and sorbitan fatty acid esters, is a paste or a semisolid at room temperature when preparing a stock solution. Oxyethylene (6) sorbitan monostearate alone or polyoxyethylene (20)
Sorbitan monostearate, polyoxyethylene (2
0) Mixtures of sorbitan tristearate and sorbitan monostearate are preferred. The blending amount of these is 0.
5 to 8% by weight, preferably 0.5 to 4% by weight.

【0006】また、溶媒は水と低級アルコールの混合物
であるが、その重量比が30:70〜70:30の範囲
のものが好ましい。噴射剤には液化ガスを用いるが、液
化ガスとしては、ジメチルエーテル、n−ブタン、イソ
ブタン、プロパンあるいはこれらの混合物を用いること
ができる。この中でもジメチルエーテルを80重量%以
上含有する噴射剤が好ましい。噴射剤の配合量は製剤全
体の40〜80重量%、好ましくは50〜70重量%で
ある。
Further, the solvent is a mixture of water and a lower alcohol, and the weight ratio thereof is preferably in the range of 30:70 to 70:30. A liquefied gas is used as the propellant, and dimethyl ether, n-butane, isobutane, propane or a mixture thereof can be used as the liquefied gas. Among these, a propellant containing 80% by weight or more of dimethyl ether is preferable. The compounding amount of the propellant is 40 to 80% by weight, preferably 50 to 70% by weight, based on the whole preparation.

【0007】なお、本発明のエアゾール剤には、鎮痒剤
や抗真菌剤に通常配合される成分、例えば鎮痒薬(クロ
タミトン、イクタモール、モクタモール、チモール酸
等)、抗真菌薬(トルナフテート、硝酸ミコナゾール
等)、抗ヒスタミン薬(ジフェンヒドラミン、塩酸ジフ
ェンヒドラミン、塩酸イソチペンジル、マレイン酸クロ
ルフェニラミン等)、局所麻酔薬(リドカイン、塩酸ジ
ブカイン等)、殺菌剤(ヨウ化カリウム、グルコン酸ク
ロルヘキシジン、アクリノール、塩化ベンザルコニウム
等)、消炎剤(アラントイン、グリチルレチン酸、サリ
チル酸メチル等)、抗酸化剤(ジブチルヒドロキシトル
エン等)、溶解補助剤(アジピン酸ジイソプロピル、ミ
リスチン酸イソプロピル、乳酸、水酸化ナトリウム
等)、香料等を本発明の効果を損なわない範囲で配合す
ることができる。
In the aerosol composition of the present invention, the components usually contained in antipruritic agents and antifungal agents, for example, antipruritic agents (crotamiton, ictamol, moctamol, thymolic acid, etc.), antifungal agents (tornaftate, miconazole nitrate, etc.) ), Antihistamines (diphenhydramine, diphenhydramine hydrochloride, isothipendyl hydrochloride, chlorpheniramine maleate, etc.), local anesthetics (lidocaine, dibucaine hydrochloride, etc.), bactericides (potassium iodide, chlorhexidine gluconate, acrinol chloride, benzalkonium chloride) Etc.), anti-inflammatory agents (allantoin, glycyrrhetinic acid, methyl salicylate, etc.), antioxidants (dibutylhydroxytoluene, etc.), solubilizers (diisopropyl adipate, isopropyl myristate, lactic acid, sodium hydroxide, etc.), fragrances, etc. Effect of invention It can be added in amounts not detrimental to the.

【0008】本発明のエアゾール剤は、噴射剤以外の成
分を加温、混合、撹拌して溶解あるいは均一に分散させ
て液剤を調製した後、この液剤をエアゾール容器に噴射
剤と共に充填することにより製造することができる。
The aerosol of the present invention is prepared by heating, mixing, stirring and dissolving or uniformly dispersing components other than the propellant to prepare a liquid, and then filling the liquid with the propellant in an aerosol container. It can be manufactured.

【0009】[0009]

【発明の効果】以上の組成のエアゾール剤にすることに
より、エアゾール剤噴射時に原液がシャーベット状とな
り、単にアルコールや噴射剤を噴射したとき以上の冷却
効果が得られ、さらにメントールとカンフルを特定の比
率で配合することにより特異的な鎮痒効果効果が得られ
る。従って、本発明により、虫刺されによる即時反応の
痒みや水虫の痒みを即時的かつ持続的に和らげるエアゾ
ール剤を提供することが可能となった。
EFFECTS OF THE INVENTION By using the aerosol composition having the above composition, the stock solution becomes sherbet-like at the time of spraying the aerosol, and the cooling effect more than that obtained by simply spraying alcohol or propellant can be obtained, and further menthol and camphor can be specified. A specific antipruritic effect can be obtained by mixing in a ratio. Therefore, according to the present invention, it is possible to provide an aerosol agent which can immediately and continuously relieve the itch of immediate reaction due to insect bites and the itch of athlete's foot.

【0010】[0010]

【実施例】以下、実施例及び試験例を挙げて、本発明を
更に詳細に説明する。 実施例1原液 成分 配合量(g) リドカイン 0.6 ジフェンヒドラミン 0.3 メントール 0.6 カンフル 0.6 ニッコールTS−10[ホ゜リオキシエチレン(20)ソルヒ゛タン モノステアレートの商品名] 0.9 ニッコールTS−30[ホ゜リオキシエチレン(20)ソルヒ゛タン トリステアレートの商品名] 0.6 ニッコールSS−10[ソルヒ゛タンモノステアレートの商品名] 0.9 エチルアルコール 10.5 精製水 全30ml 噴射剤 ジメチルエーテル 70ml 原液の各成分を加温、混合、撹拌して均一にし原液を調
製した後、この原液をエアゾール容器に噴射剤と共に充
填し、エアゾール剤を製造した。
EXAMPLES The present invention will be described in more detail below with reference to examples and test examples. Example 1 stock Ingredients Amounts (g) Lidocaine 0.6 Diphenhydramine 0.3 Menthol 0.6 Camphor 0.6 Nikkol TS-10 [polyoxyethylene (20) Soruhi Keypad tradename monostearate] 0.9 Nikkor TS -30 [Product name of polyoxyethylene (20) sorbitan tristearate] 0.6 Nikkor SS-10 [Product name of sorbitan monostearate] 0.9 Ethyl alcohol 10.5 Purified water Total 30 ml Propellant dimethyl ether 70 ml Undiluted solution Each component of (1) was heated, mixed and stirred to make it uniform, and a stock solution was prepared, and then this stock solution was filled in an aerosol container together with a propellant to produce an aerosol agent.

【0011】実施例2,3及び比較例1〜3 表1に示す処方を用い、実施例1と同様の方法でエアゾ
ール剤を製造した。 比較例4 表1に示す処方を用いて原液を調製し、そのまま液剤と
して用いた。
Examples 2 and 3 and Comparative Examples 1 to 3 Using the formulations shown in Table 1, an aerosol agent was produced in the same manner as in Example 1. Comparative Example 4 A stock solution was prepared using the formulation shown in Table 1 and used as it was as a liquid agent.

【0012】[0012]

【表1】 [Table 1]

【0013】試験例 (試験方法) 手の甲に直径5mmの穴を開けたゴム手袋を着用し、
ヒトスジシマカの入ったゲージに手を差し込む。 蚊1匹に吸血させる。 充分に吸血したら手を抜き、ゴム手袋を外す。 痒みの程度が耐えがたくなったら検体(実施例2,3
及び比較例1〜3で製造したエアゾール剤)を適量(3
cmの距離から1〜3秒)塗布する。また、比較例4で
製造した液剤は適量を塗布する。 塗布直後から、1分ごとに痒みの程度を自己判定(表
2参照)する。コントロールは痒みの程度が耐えられな
くなった時を0分とし、何も処置しない。
Test Example (Test Method) Wear rubber gloves with a 5 mm diameter hole on the back of the hand,
Insert your hand into the gauge containing Aedes albopictus. Make one mosquito suck blood. When you have sufficiently sucked blood, remove your hands and remove the rubber gloves. If the degree of itching becomes unbearable, the sample (Examples 2 and 3)
And an appropriate amount of the aerosol agent produced in Comparative Examples 1 to 3 (3
Apply from a distance of 1 to 3 seconds). Further, the liquid agent produced in Comparative Example 4 is applied in an appropriate amount. Immediately after application, the degree of itching is self-determined every minute (see Table 2). The control is 0 minutes when the degree of itchiness becomes intolerable, and no treatment is performed.

【0014】[0014]

【表2】 [Table 2]

【0015】(結果)結果を被検者5人の平均値として
図1及び図2に示す。実施例2及び3で調製した本発明
のエアゾール剤では、痒みスコアのピークが1以下、す
なわちほとんど痒くない状態であり、生活者にとって有
効な痒み抑制効果が得られることがわかった。
(Results) The results are shown in FIGS. 1 and 2 as an average value of five subjects. It was found that with the aerosol preparations of the present invention prepared in Examples 2 and 3, the pruritus score peak was 1 or less, that is, there was almost no pruritus, and an effective pruritus-suppressing effect for consumers was obtained.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明のエアゾール剤及び比較例4の液剤の鎮
痒効果を示す図で、縦軸は痒みスコア、横軸は時間
(分)を表す。
FIG. 1 is a diagram showing the antipruritic effect of the aerosol of the present invention and the liquid preparation of Comparative Example 4, in which the vertical axis represents the itch score and the horizontal axis represents the time (minutes).

【図2】本発明のエアゾール剤と比較するエアゾール剤
の鎮痒効果を示す図で、縦軸は痒みスコア、横軸は時間
(分)を表す。
FIG. 2 is a graph showing the antipruritic effect of an aerosol agent compared with the aerosol agent of the present invention, in which the vertical axis represents the pruritus score and the horizontal axis represents time (minutes).

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 //(A61K 31/045 31:125) (72)発明者 木村 文紀 東京都豊島区高田3丁目24番1号 大正製 薬株式会社内 (72)発明者 加藤 恵子 東京都豊島区高田3丁目24番1号 大正製 薬株式会社内─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification number Reference number within the agency FI technical display location // (A61K 31/045 31: 125) (72) Inventor Fumiki Kimura 3 Takada, Toshima-ku, Tokyo No. 24-1 Taisho Pharmaceutical Co., Ltd. (72) Inventor Keiko Kato 3-24-1, Takada, Toshima-ku, Tokyo Taisho Pharmaceutical Co., Ltd.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 水と低級アルコールとの混合溶媒に、次
の(A)〜(C)の成分を配合した原液及び噴射剤から
なるエアゾール剤。 (A)ポリオキシエチレンソルビタン脂肪酸エステル類
及びソルビタン脂肪酸エステル類からなる群より選ばれ
る界面活性剤1種または2種以上 (B)メントール0.5〜8重量% (C)メントール1重量部に対して1〜0.5重量部の
カンフル
1. An aerosol agent comprising a stock solution and a propellant in which the following components (A) to (C) are mixed in a mixed solvent of water and a lower alcohol. (A) one or more surfactants selected from the group consisting of polyoxyethylene sorbitan fatty acid esters and sorbitan fatty acid esters (B) menthol 0.5 to 8 wt% (C) to 1 part by weight of menthol 1 to 0.5 parts by weight camphor
【請求項2】 噴射剤がジメチルエーテル含有量80重
量%以上で構成される請求項1記載のエアゾール剤。
2. The aerosol composition according to claim 1, wherein the propellant has a dimethyl ether content of 80% by weight or more.
【請求項3】 噴射剤の配合量が製剤全体の50〜70
重量%である請求項1または2記載のエアゾール剤。
3. The compounding amount of the propellant is 50 to 70 of the whole preparation.
The aerosol composition according to claim 1 or 2, which is contained in a weight percentage.
JP8206774A 1995-08-10 1996-08-06 Aerosol preparation Pending JPH09110677A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8206774A JPH09110677A (en) 1995-08-10 1996-08-06 Aerosol preparation

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7-204799 1995-08-10
JP20479995 1995-08-10
JP8206774A JPH09110677A (en) 1995-08-10 1996-08-06 Aerosol preparation

Publications (1)

Publication Number Publication Date
JPH09110677A true JPH09110677A (en) 1997-04-28

Family

ID=26514675

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8206774A Pending JPH09110677A (en) 1995-08-10 1996-08-06 Aerosol preparation

Country Status (1)

Country Link
JP (1) JPH09110677A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998056350A1 (en) * 1997-06-13 1998-12-17 Taisho Pharmaceutical Co., Ltd. Aerosols

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998056350A1 (en) * 1997-06-13 1998-12-17 Taisho Pharmaceutical Co., Ltd. Aerosols
AU729680B2 (en) * 1997-06-13 2001-02-08 Taisho Pharmaceutical Co., Ltd. Aerosol preparation
US6231835B1 (en) 1997-06-13 2001-05-15 Taisho Pharmaceutical Co., Ltd. Aerosol preparation for skin cooling

Similar Documents

Publication Publication Date Title
US5776430A (en) Topical antimicrobial cleanser containing chlorhexidine gluconate and alcohol
JP4213211B2 (en) Skin penetration enhancer and drug delivery system including the same
US5906808A (en) Process of preparing a topical antimicrobial cleanser
US5990100A (en) Composition and method for treatment of psoriasis
EP0957939B1 (en) Use of an emulsifier system for increasing penetration flux of pharmaceutical agents
US20070048360A1 (en) Pharmaceutical compositions with melting point depressant agents and method of making same
US20090098069A1 (en) Transdermal, alcohol-free, pharmaceutical compositions
EA019760B1 (en) Transdermal delivery system, method for transdermal administration and method of preparing transdermal delivery system
JP3487633B2 (en) Skin disease treatment emulsion
AU2003228612A1 (en) Pharmaceutical composition
EP1409022A1 (en) Pharmaceutical vehicle
JP2555555B2 (en) Antifungal topical formulation
MX2007015255A (en) Method and composition for transdermal drug delivery.
JPS6272611A (en) Skin external preparation
JP3038837B2 (en) Aerosol for skin cooling
TWI363617B (en) Low irritant adhesive dressing
JPH08291049A (en) Nonaqueous oily ointment base material and ointment for skin external use
JPH09110677A (en) Aerosol preparation
US6627663B2 (en) Noninvasive method for treating hemangiomas through transdermal delivery of calcium channel blocker agents and medicament for use in such method
JP4450545B2 (en) Aerosol formulation
WO1997005858A1 (en) Aerosol preparation
JP4176858B2 (en) Aerosol formulation
JP4176859B2 (en) Aerosol formulation
JP2005170913A (en) Antifungal composition for external use
JP4545244B2 (en) Ophthalmic agent

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20040818

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040824

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050712

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20060407